ENDONOVO THERAPEUTICS, INC. Business Finance Contracts & Agreements
31 Contracts & Agreements
- Exchange Agreements (2 contracts)
- Investment Agreements (1)
- Note Agreements (9)
- Purchase Agreements (8)
- Registration Rights Agreements (4)
- Security Agreements (3)
- Stock Agreements (3)
- Warrant Agreements (1)
- Asset Purchase Agreement (Filed With SEC on December 4, 2023)
- Asset Purchase Agreement (Filed With SEC on September 27, 2022)
- Form of Note Modification and Forbearance Agreement (Filed With SEC on May 26, 2020)
- Registration Rights Agreement by and between the Company and Calvary Fund I, LP, dated as of May 18, 2020 (Filed With SEC on May 26, 2020)
- Equity Line Purchase Agreement by and between the Company and Calvary Fund I, LP, dated as of May 18, 2020 (Filed With SEC on May 26, 2020)
- Registration Rights Agreement by and between the Company and Azure Capital, dated as of December 31, 2018 (Filed With SEC on January 3, 2019)
- Investment Agreement by and between the Company and Azure Capital, dated as of December 31, 2018 (Filed With SEC on January 3, 2019)
- 10% Senior Secured Convertible Redeemable Note Due November 30, 2019 (Filed With SEC on December 7, 2018)
- Exchange Agreement, dated as of November 30, 2018, between the Company and Eagle Equities, Inc (Filed With SEC on December 7, 2018)
- Debt Purchase Agreement, dated April 7, 2017, by and among the Company, Eagle and Bellridge Capital, LLC (Filed With SEC on April 6, 2018)
- Form of Back End Note under the SPA (Filed With SEC on April 6, 2018)
- Form of Note Payable to Eagle under the SPA (Filed With SEC on April 6, 2018)
- Specimen Common Stock Certificate (Filed With SEC on April 6, 2018)
- The Warrant (Filed With SEC on December 28, 2017)
- Security Agreement (Filed With SEC on December 28, 2017)
- Security Agreement (Filed With SEC on December 28, 2017)
- Security Purchase Agreement, dated December 21, 2017, between the Registrant and Eagle (Filed With SEC on December 28, 2017)
- Security Agreement, between the Registrant and the holders of the Series C Secured Redeemable Preferred Stock (Filed With SEC on December 26, 2017)
- Certificate of Designation of the Series C Secured Redeemable Preferred Stock (Filed With SEC on December 26, 2017)
- Security Agreement, dated December 22, 2017, between the Registrant and Steven Gluckstern (Filed With SEC on December 26, 2017)
- Secured Promissory Note, dated December 22, 2017, payable to Steven Gluckstern (Filed With SEC on December 26, 2017)
- ENDONOVOTHERAPEUTICS, INC. 10%CONVERTIBLE REDEEMABLE NOTE DUEAPRIL 7, 2018 BACKEND NOTE (Filed With SEC on April 17, 2017)
- ENDONOVOTHERAPEUTICS, INC. 10%CONVERTIBLE REDEEMABLE NOTE DUEAPRIL 7, 2018 (Filed With SEC on April 17, 2017)
- AMENDEDAND RESTATED SECURITIES PURCHASE AGREEMENT (Filed With SEC on October 6, 2016)
- REGISTRATIONRIGHTS AGREEMENT (Filed With SEC on July 15, 2016)
- 6%Senior Convertible NOTE (Filed With SEC on July 15, 2016)
- 10% PER ANNUM, $250,000CONVERTIBLE NOTE (Filed With SEC on June 13, 2016)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on January 21, 2015)
- EQUITY PURCHASE AGREEMENT (Filed With SEC on January 21, 2015)
- ASSET PURCHASE AGREEMENT (Filed With SEC on November 19, 2013)
- SHARE EXCHANGE AGREEMENT (Filed With SEC on March 21, 2012)
